RAMP - RAMP

オプションチェーンは、LiveRamp Holdingsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、LiveRamp Holdingsの市場センチメントを評価します。.

LiveRamp Holdings (NYSE:RAMP) 株価情報, オプションチェーン

LIVERAMP HOLDINGS INC

LiveRamp Holdings

LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.

LiveRamp Holdings Inc

RAMP

POLARIS RENEWABLE ENERGY by POLARIS RENEWABLE ENERGY INC.

Polaris Renewable Energy Inc

RAMP METALS INC by RAMP METALS INC.

Transcat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) will release its fourth-quarter financial results after the closing <a href="https://www.benzinga.com/quote/TRNS/earnings">bell on Monday, May 19</a>.
Analysts expect the Rochester, New York-based company to report quarterly earnings at 62 cents per share, down from 66 cents per share in the year-ago period. Transcat projects quarterly revenue of $76.4 million, compared to $70.91 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 27, Transcat posted mixed results for the third quarter.
Transcat shares gained 0.5% to close at $81.25 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TRNS/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Oppenheimer analyst Martin Yang downgraded the stock from Outperform to Perform on Jan. 29, 2025. This analyst has an accuracy rate of 77%.</li>
<li>Craig-Hallum analyst Greg Palm maintained a Buy rating and raised the price target from $113 to $125 on Dec. 12, 2024. This analyst has an accuracy rate of 69%.</li>
</ul>
Considering buying TRNS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="608" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/18082819/image-216-1024x608.png" alt="" class="wp-image-918907" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/18082819/image-216-1024x608.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/18082819/image-216-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/18082819/image-216-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/18082819/image-216.png 1115w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45466849/top-3-consumer-stocks-that-may-fall-off-a-cliff-in-q2">Top 3 Consumer Stocks That May Fall Off A Cliff In Q2</a></li>
</ul>

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

TRNS

Transcat Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Morgan Stanley analyst Bob Huang maintains Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) with a Overweight and raises the price target from $32 to $37.

CRBG

Morgan Stanley Maintains Overweight on Corebridge Financial, Raises Price Target to $37

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Seaport Global analyst David Joyce initiated coverage on Starz Entertainment Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRZ#NASDAQ">STRZ</a>) with a Buy rating and announced a price target of $30. Starz Entertainment shares closed at $13.01 on Friday. <a href="https://www.benzinga.com/quote/strx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barrington Research analyst Kevin Steinke initiated coverage on Mobile Infrastructure Corporation (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) with an Outperform rating and announced a price target of $6.5. Mobile Infrastructure shares closed at $3.76 on Friday. <a href="https://www.benzinga.com/quote/beep/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying STRZ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="607" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-1024x607.png" alt="" class="wp-image-919755" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-1024x607.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231-768x455.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/19082719/image-231.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

Initiation

Pre-Market Outlook

Mobile Infrastructure Corporation Common Stock

BEEP

NFLX

RDDT

STRZ

This Starz Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Monday

Morgan Stanley analyst Jeffrey Hung maintains Contineum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) with a Overweight and lowers the price target from $25 to $20.

CTNM

Morgan Stanley Maintains Overweight on Contineum Therapeutics, Lowers Price Target to $20

JP Morgan analyst Richard Sunderland maintains Portland Gen Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) with a Neutral and lowers the price target from $46 to $45.

JP Morgan Maintains Neutral on Portland Gen Electric, Lowers Price Target to $45

Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) has received limited approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Nuvaxovid, marking a regulatory milestone and unlocking a <a href="https://www.benzinga.com/pressreleases/25/05/n45489838/u-s-fda-approves-bla-for-novavaxs-covid-19-vaccine" target="_blank" rel="noreferrer noopener">$175 million milestone payment</a> from partner Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>).
The protein-based vaccine, distinct from mRNA options by Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>), is now authorized for people aged 65 and older and for individuals 12 and up with underlying medical conditions that increase the risk of severe COVID-19. 
The approval came after a six-week delay as regulators sought additional data.
Related: <a href="https://www.benzinga.com/government/regulations/25/05/45488265/novavax-wins-limited-fda-nod-for-covid-shot-cleared-only-for-seniors-high-risk-groups-amid-safety-scrutiny" target="_blank" rel="noreferrer noopener">Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny</a>         
Novavax CEO John C. Jacobs called the decision "a significant milestone" and emphasized the company's commitment to vulnerable populations. The CDC has noted that these groups will most likely seek seasonal COVID vaccinations.
The approval comes as CDC advisers weigh adjustments to annual COVID shot guidance, potentially narrowing recommendations to older adults and high-risk groups.
Novavax plans to begin commercial distribution of its 2025–2026 formula this fall, pending strain selection at the FDA advisory committee meeting on May 22. The company is also working with Sanofi to fund a Phase 4 study in adults 50–64 without high-risk conditions, as requested by the FDA.
Financially, Novavax reaffirmed its 2025 forecast for R&amp;D and SG&amp;A expenses between $475 million and $525 million. It plans to cut these to around $350 million in 2026 and $250 million by 2027, according to BZ Pro.
Related ETFs: iShares Biotechnology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBB#NASDAQ">IBB</a>), SPDR S&amp;P Biotech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XBI#NYSE">XBI</a>)
Price Action: NVAX shares are trading higher by 19.0% at $8.01 premarket at the last check on Monday.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45495742/nvidia-unveils-ai-tools-for-humanoid-robots-launches-quantum-ai-supercomputer-to-drive-next-tech-era">Nvidia Unveils AI Tools For Humanoid Robots, Launches Quantum-AI Supercomputer To Drive Next Tech Era</a></li>
</ul>
Image: Shutterstock

BNTX

MRNA

NVAX

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment

Morgan Stanley analyst Michael Phillips maintains Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) with a Equal-Weight and raises the price target from $280 to $300.

Morgan Stanley Maintains Equal-Weight on Chubb, Raises Price Target to $300

Benchmark analyst Mark Zgutowicz maintains Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) with a Buy and lowers the price target from $260 to $245.

Benchmark Maintains Buy on Wix.com, Lowers Price Target to $245

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) showcased a new lineup of graphics processing units (GPUs) and AI accelerators designed for professionals and developers at <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45489409/computex-2025-intel-unveils-new-gpus-for-ai-and-workstations" rel="noreferrer noopener">the Computex 2025</a> on Monday.
Intel launched Arc Pro B60 and B50 graphics processing units for workstations and AI inference.
During the May 20-23 event in Taipei, Taiwan, Intel marks 40 years of collaboration with local ecosystem partners and expands its GPU lineup, AI accelerator capabilities, and AI assistant availability.
Also Read: <a href="https://www.benzinga.com/media/25/05/45456613/intel-cfo-says-new-chip-output-for-clients-will-be-minimal-eyes-foundry-breakeven-by-2027" target="_blank" rel="noreferrer noopener">Intel CFO Says New Chip Output For Clients Will Be Minimal, Eyes Foundry Breakeven By 2027</a>
Intel announces Intel&nbsp;Arc Pro B60 and Intel&nbsp;Arc Pro B50 GPUs, expanding the&nbsp;Intel&nbsp;Arc Pro family&nbsp;with configurations tailored for AI inference and professional workstations.
Intel&nbsp;Gaudi&nbsp;3 AI accelerators&nbsp;are now available in PCIe and rack-scale systems, offering scalable, open solutions for enterprise and cloud AI inferencing.
Now publicly available on GitHub,&nbsp;Intel&nbsp;AI Assistant Builder&nbsp;enables developers to create local, purpose-built AI agents optimized for Intel platforms.
This week&#8217;s product launches coincide with Intel&#8217;s 40th anniversary in Taiwan, which marks four decades of collaboration.
New Intel Arc Pro B60 and B50 GPUs based on the Xe2 architecture feature Intel&nbsp;Xe&nbsp;Matrix Extensions (XMX) AI cores and advanced ray tracing units, bringing high-performance capabilities to creators, developers, and engineers.
Expanding Intel&#8217;s GPU lineup for professionals, new Intel Arc Pro B60 and Intel Arc Pro B50 GPUs are designed for demanding AI inference workloads and workstation applications.
The GPUs are optimized for AEC (architecture, engineering, construction) and inference workstations, offering stability and performance through various independent software vendor (ISV) certifications and optimized software.
The Intel Arc Pro B-Series GPUs are compatible with consumer and pro drivers on Windows.
On Linux, the GPUs support a containerized software stack to simplify AI deployments and will be progressively upgraded with features and optimizations.
The Intel Arc Pro B-Series offers creators and AI developers scalable, cost-effective solutions by combining high memory capacity with key software compatibility.
Intel also revealed a configurable workstation-class Intel&nbsp;Xeon-based platform (code-named Project Battlematrix) designed to reduce friction points for AI developers.
It supports up to eight Intel Arc Pro B60 24GB GPUs to enable medium-size (up to 150 billion parameters) and accurate AI models with up to 192GB of video random-access memory.
Intel chief Lip-Bu Tan told Reuters on Monday that the company has a 55% share of the data center market.
Recently, Intel announced that <a href="https://www.benzinga.com/media/25/04/45079217/intel-ramps-up-new-chip-tech-to-take-on-taiwan-semiconductors-global-lead" target="_blank" rel="noreferrer noopener">several contract manufacturing</a> customers planned to&nbsp;build test chips&nbsp;for its forthcoming advanced manufacturing process as it struggles to win market share from Taiwan Semiconductor Manufacturing Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
Price Actions: INTC stock is down 1.45% at $21.34 at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45384346/amd-launches-epyc-4005-chips-for-small-business-and-cloud" target="_blank" rel="noreferrer noopener">AMD Launches EPYC 4005 Chips For Small Business And Cloud</a></li>
</ul>
Photo: Tada Images/ Shutterstock.com

Tech

Media

INTC

Intel's Next-Gen AI Tech Steals The Show At Computex 2025

JP Morgan analyst Anne Samuel maintains IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Overweight and lowers the price target from $232 to $177.

JP Morgan Maintains Overweight on IQVIA Hldgs, Lowers Price Target to $177

Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) with a Overweight and lowers the price target from $55 to $52.

CGON

Morgan Stanley Maintains Overweight on CG Oncology, Lowers Price Target to $52

Morgan Stanley analyst Nigel Dally maintains Brighthouse Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>) with a Underweight and raises the price target from $41 to $45.

Brighthouse Financial, Inc. - Common Stock

Morgan Stanley Maintains Underweight on Brighthouse Finl, Raises Price Target to $45

JP Morgan analyst Tien-Tsin Huang maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Overweight and lowers the price target from $211 to $210.

JP Morgan Maintains Overweight on Fiserv, Lowers Price Target to $210

Morgan Stanley analyst Bob Huang maintains Bowhead Specialty Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOW#NYSE">BOW</a>) with a Equal-Weight and raises the price target from $36 to $39.

Morgan Stanley Maintains Equal-Weight on Bowhead Specialty Hldgs, Raises Price Target to $39

JP Morgan analyst Jeremy Tonet maintains Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) with a Overweight and lowers the price target from $25 to $23.

JP Morgan Maintains Overweight on Energy Transfer, Lowers Price Target to $23

Fastenal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) has outperformed the market over the past 20 years by 4.77% on an annualized basis producing an average annual return of 13.08%. Currently, Fastenal has a market capitalization of $47.35 billion. 
Buying $1000 In FAST: If an investor had bought $1000 of FAST stock 20 years ago, it would be worth $11,745.80 today based on a price of $82.55 for FAST at the time of writing.
<h3>Fastenal's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747665013_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAST

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Benchmark analyst Mike Hickey reiterates Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) with a Sell and maintains $35 price target.

Reiteration

SPHR

Benchmark Reiterates Sell on Sphere Entertainment, Maintains $35 Price Target

Morgan Stanley analyst Bob Huang maintains Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>) with a Equal-Weight and raises the price target from $200 to $217.

Morgan Stanley Maintains Equal-Weight on Assurant, Raises Price Target to $217

Morgan Stanley analyst Michael Phillips maintains Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) with a Overweight and raises the price target from $105 to $110.

ACGL

Morgan Stanley Maintains Overweight on Arch Capital Group, Raises Price Target to $110

Benchmark analyst Mike Hickey reiterates PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) from Hold to Hold.

PENN

Benchmark Reiterates Hold on PENN Entertainmentto Hold

Press Releases

LiveRamp Announces Results for Third Quarter FY25

LiveRamp to Present at the Morgan Stanley Technology, Media & Telecom Conference

LiveRamp Pioneers Cross-Media Intelligence, Transforming Measurement for the Modern Marketer

From Fierce Rivals to Partners: Omar Tawakol joins super{set}, a venture studio that builds AI-powered, category-defining companies

LiveRamp Announces Collaboration with Western Union Media Network to Unlock Multicultural Audiences for Advertisers

Performance Unlocked: AdOmni and LiveRamp Bring New Targeting and Attribution to CTV, OLV, and DOOH

Canadian Investment Regulatory Organization Trade Resumption - RAMP

LiveRamp to Discuss Fiscal 2025 Fourth Quarter and Full Year Results

LiveRamp and REMAX Media Network Unlock the Full Homebuying Journey for Advertisers Through New Clean Room Integration

LiveRamp Named a Leader in 2025 IDC MarketScape: Worldwide Data Clean Room Technology for Advertising and Marketing Use Cases

RMAX

TSXV:RAMP

Agilysys

Alarm.com Holdings

Amplitude

Bitdeer Technologies Group - Ordinary Shares

Bitdeer Technologies

Cleanspark

Sprinklr

Diginex

DoubleVerify Holdings

EverCommerce

Five9

IREN

Jamf Holding

Karooooo

Ncino

NextNav

Opera Limited - American Depositary Shares

Opera

PagerDuty

Quantum Computing

RingCentral

SEMrush Holdings, Inc. Class A Common Stock

SEMrush Hldgs

Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share

Comments

LiveRamp Holdings

LiveRamp Holdings (RAMP) オプション

LiveRamp Holdings (NYSE:RAMP) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル